Italian Startup Secures $5.4M to Scale Rehab Robotics & Exoskeletons

Jan de Vries · 2026-04-03

Here's some exciting news from the world of medical tech. An Italian startup called Wearable Robotics just landed a major funding round to push their innovative rehab robots and exoskeletons further into the global market. They're based in Pisa, and their focus is on something truly transformative: using wearable robotics for neuromotor rehabilitation. Think helping people regain movement after a stroke or spinal cord injury. They closed a Series A round worth about $5.4 million. That's a serious vote of confidence. The goal? To accelerate their global expansion and get these life-changing technologies into key markets where they're needed most. ### Who Backed This Vision? The funding was led by CDP Venture Capital through their Accelerators Fund. They weren't alone, though. A whole consortium of investors came together, including MITO Technology, LIFTT, and SIMEST. It also involved RoboIT, which is Italy's national hub for robotics tech transfer, and a regional co-investment fund called Toscana Next. This shows a deep, multi-layered belief in the company's potential, from national to local levels. Lucia Lencioni, the CEO, put it perfectly. She said, "The closing of this round represents a crucial step in our evolution. We are building the foundation for sustainable and scalable growth." She emphasized their goal is to create advanced, modular solutions that make a real impact across the entire rehabilitation journey. ### What Does Wearable Robotics Actually Do? Let's break it down. Founded back in 2014 as a spin-off from the prestigious Scuola Superiore Sant'Anna, this company is all about building robots you can wear. Their devices are designed for three main areas: - Rehabilitation: Helping patients recover motor functions. - Movement Assistance: Aiding with walking or daily tasks. - Human Capacity Augmentation: Think industrial exoskeletons that help workers lift heavy loads safely. They cleverly split their work into two divisions. First, there's **NEXUM Medical**. This branch is purely about medical tech. They design and sell robotic devices, especially for the upper limbs, and even integrate virtual reality (VR) to make rehab more engaging and effective. Then there's **NEXUM Industry**. This side develops exoskeletons for workers in factories or warehouses. The idea is to reduce fatigue and prevent those all-too-common musculoskeletal injuries by providing supportive force when handling heavy objects. It's about keeping people healthy on the job. ### Where's the Money Going? So, what's the plan for that $5.4 million? The company has a clear roadmap. A big part of it is expanding their product portfolio and boosting their commercial development to compete on the world stage. Their flagship product, the ALEX RS, is already a reference point in upper-limb rehab robotics, with over 50 units installed internationally. The funding will help build on that success. They also need to navigate the complex world of medical regulations. A significant chunk of investment will go toward completing the necessary processes to access new markets. Getting those approvals is crucial for speeding up how quickly their tech can reach patients and workers. Finally, they'll be strengthening their sales and distribution channels globally. It's a comprehensive strategy for growth—from the lab to the clinic and the factory floor. It's a fascinating case of deep tech meeting real human need. This isn't just about robots; it's about restoring independence and improving quality of life. With this new capital, Wearable Robotics is poised to scale up and bring its supportive technology to many more people around the world.